What do you think is possible with this one? Instead of rejecting the product, can the FDA just request more time/information? If so, then that kind of news could give this a little run.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.